1. Home
  2. EDSA vs HUBC Comparison

EDSA vs HUBC Comparison

Compare EDSA & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • HUBC
  • Stock Information
  • Founded
  • EDSA 2015
  • HUBC 2017
  • Country
  • EDSA Canada
  • HUBC Israel
  • Employees
  • EDSA N/A
  • HUBC N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • HUBC
  • Sector
  • EDSA Health Care
  • HUBC
  • Exchange
  • EDSA Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • EDSA 13.8M
  • HUBC 21.7M
  • IPO Year
  • EDSA N/A
  • HUBC N/A
  • Fundamental
  • Price
  • EDSA $2.08
  • HUBC $1.86
  • Analyst Decision
  • EDSA Strong Buy
  • HUBC
  • Analyst Count
  • EDSA 2
  • HUBC 0
  • Target Price
  • EDSA $13.00
  • HUBC N/A
  • AVG Volume (30 Days)
  • EDSA 15.4K
  • HUBC 1.5M
  • Earning Date
  • EDSA 08-08-2025
  • HUBC 05-01-2025
  • Dividend Yield
  • EDSA N/A
  • HUBC N/A
  • EPS Growth
  • EDSA N/A
  • HUBC N/A
  • EPS
  • EDSA N/A
  • HUBC N/A
  • Revenue
  • EDSA N/A
  • HUBC $29,562,000.00
  • Revenue This Year
  • EDSA N/A
  • HUBC N/A
  • Revenue Next Year
  • EDSA N/A
  • HUBC N/A
  • P/E Ratio
  • EDSA N/A
  • HUBC N/A
  • Revenue Growth
  • EDSA N/A
  • HUBC N/A
  • 52 Week Low
  • EDSA $1.55
  • HUBC $1.72
  • 52 Week High
  • EDSA $5.59
  • HUBC $14.00
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 55.28
  • HUBC 33.89
  • Support Level
  • EDSA $1.99
  • HUBC $1.78
  • Resistance Level
  • EDSA $2.11
  • HUBC $2.42
  • Average True Range (ATR)
  • EDSA 0.11
  • HUBC 0.28
  • MACD
  • EDSA 0.02
  • HUBC -0.02
  • Stochastic Oscillator
  • EDSA 72.41
  • HUBC 9.41

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: